This website is intended for US healthcare professionals only.

  • Contact Us
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
  • Disease State Information & Resources
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
BioCryst logo
  • BioCryst logo
  • Clinical Trials
  • Congresses
  • Publications
    • Hereditary Angioedema (HAE)
    • Netherton Syndrome (NS)
    • Diabetic Macular Edema (DME)
    • Complement-Mediated Diseases
    • Contact BioCryst
    • Submit an Inquiry
    • Request a Grant or Sponsorship
    • Expanded-Access Program
  • Search Medical Information
  • Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • The Multifactorial Impact of Receiving a Hereditary Angioedema Diagnosis

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Hereditary Angioedema Management: Individualization

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Physician and Patient Perspectives on the Management of Hereditary Angioedema: A Survey on Treatment Burden and Needs

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Caregivers’ Role in Managing Hereditary Angioedema and Perceptions of Treatment-Related Burdens

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Patient Perspectives on the Treatment Burden of Injectable Medication for Hereditary Angioedema

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Insights into the Treatment Burden of Hereditary Angioedema in the Evolving Treatment Landscape

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Time Trade‑Off Utilities for Hereditary Angioedema Health and Caregiver States

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
  • Hereditary angioedema in children: Review and practical perspective for clinical management

    View Article

    biocryst

    February 12, 2025
    Hereditary Angioedema (HAE)
1 2 3 … 9
Next Page
BioCryst logo

2025 BioCryst Pharmaceuticals, Inc.
All Rights Reserved

  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Site Map
Close

You are now leaving biocrystmedical.com.

BioCryst is not responsible for and has no control over the content of linked sites.

Stay on Site Continue

This website is intended for healthcare professionals practicing in the US.

Are you a US healthcare professional? If not, you will be redirected to biocryst.com.

No, I am not a US healthcare professional Yes, I am a US healthcare professional